These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

751 related articles for article (PubMed ID: 24923339)

  • 21. Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders.
    García-Gutiérrez MS; Navarrete F; Gasparyan A; Austrich-Olivares A; Sala F; Manzanares J
    Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33228239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: Role of neurogenesis and dendritic remodeling.
    Fogaça MV; Campos AC; Coelho LD; Duman RS; Guimarães FS
    Neuropharmacology; 2018 Jun; 135():22-33. PubMed ID: 29510186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Novel Anti-Inflammatory Formulation Comprising Celecoxib and Cannabidiol Exerts Antidepressant and Anxiolytic Effects.
    Dinur E; Goldenberg H; Robinson E; Naggan L; Kozela E; Yirmiya R
    Cannabis Cannabinoid Res; 2024 Apr; 9(2):561-580. PubMed ID: 36520610
    [No Abstract]   [Full Text] [Related]  

  • 24. Neuroimaging studies towards understanding the central effects of pharmacological cannabis products on patients with epilepsy.
    Allendorfer JB; Szaflarski JP
    Epilepsy Behav; 2017 May; 70(Pt B):349-354. PubMed ID: 28109780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test.
    Moreira FA; Aguiar DC; Guimarães FS
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1466-71. PubMed ID: 16876926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain.
    De Gregorio D; McLaughlin RJ; Posa L; Ochoa-Sanchez R; Enns J; Lopez-Canul M; Aboud M; Maione S; Comai S; Gobbi G
    Pain; 2019 Jan; 160(1):136-150. PubMed ID: 30157131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system.
    Campos AC; Ortega Z; Palazuelos J; Fogaça MV; Aguiar DC; Díaz-Alonso J; Ortega-Gutiérrez S; Vázquez-Villa H; Moreira FA; Guzmán M; Galve-Roperh I; Guimarães FS
    Int J Neuropsychopharmacol; 2013 Jul; 16(6):1407-19. PubMed ID: 23298518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sub-chronic treatment with cannabidiol but not with URB597 induced a mild antidepressant-like effect in diabetic rats.
    de Morais H; Chaves YC; Waltrick APF; Jesus CHA; Genaro K; Crippa JA; da Cunha JM; Zanoveli JM
    Neurosci Lett; 2018 Aug; 682():62-68. PubMed ID: 29885450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabinoids: Medical implications.
    Schrot RJ; Hubbard JR
    Ann Med; 2016; 48(3):128-41. PubMed ID: 26912385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabinoids in the Treatment of Epilepsy.
    Friedman D; Devinsky O
    N Engl J Med; 2015 Sep; 373(11):1048-58. PubMed ID: 26352816
    [No Abstract]   [Full Text] [Related]  

  • 31. Prohedonic Effect of Cannabidiol in a Rat Model of Depression.
    Shoval G; Shbiro L; Hershkovitz L; Hazut N; Zalsman G; Mechoulam R; Weller A
    Neuropsychobiology; 2016; 73(2):123-9. PubMed ID: 27010632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ….
    Baron EP
    Headache; 2015 Jun; 55(6):885-916. PubMed ID: 26015168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cannabidiol in cancer treatment].
    Likar R; Köstenberger M; Nahler G
    Schmerz; 2020 Apr; 34(2):117-122. PubMed ID: 31897700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Joints for joints: cannabinoids in the treatment of rheumatoid arthritis.
    Lowin T; Schneider M; Pongratz G
    Curr Opin Rheumatol; 2019 May; 31(3):271-278. PubMed ID: 30920973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cannabinoids in Neurologic Illnesses.
    Patel AD
    Neurol Clin; 2021 Feb; 39(1):231-241. PubMed ID: 33223086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antidepressant- and Anxiolytic-Like Effects of New Dual 5-HT₁A and 5-HT₇ Antagonists in Animal Models.
    Pytka K; Partyka A; Jastrzębska-Więsek M; Siwek A; Głuch-Lutwin M; Mordyl B; Kazek G; Rapacz A; Olczyk A; Gałuszka A; Błachuta M; Waszkielewicz A; Marona H; Sapa J; Filipek B; Wesołowska A
    PLoS One; 2015; 10(11):e0142499. PubMed ID: 26554929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic Use of Δ9-THC and Cannabidiol: Evaluation of a New Extraction Procedure for the Preparation of Cannabis-based Olive Oil.
    Morini L; Porro G; Liso M; Groppi A
    Curr Pharm Biotechnol; 2017; 18(10):828-833. PubMed ID: 29189144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabidiol as a Potential Treatment for Anxiety and Mood Disorders: Molecular Targets and Epigenetic Insights from Preclinical Research.
    Melas PA; Scherma M; Fratta W; Cifani C; Fadda P
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33668469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Should ophtalmologists recommend medical cannabis to patients with glaucoma?].
    Mouhammad ZA; Kolko M
    Ugeskr Laeger; 2018 Jul; 180(29):. PubMed ID: 30020072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age.
    Crippa JA; Guimarães FS; Campos AC; Zuardi AW
    Front Immunol; 2018; 9():2009. PubMed ID: 30298064
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.